Ramosetron Hydrochloride

盐酸雷莫司琼

Report date: 2022/05/12 17:20:38
NME

Base Information

Drug NameRamosetron Hydrochloride
Drug Alias Name雷莫司琼ramosetronumramosetronIrribowNasea OD +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsVomitingNauseaIrritable Bowel Syndrome +[4] 
Global Approved IndicationsVomitingNauseaIrritable Bowel Syndrome
Approved Indications in ChinaVomitingNausea
Original Approved Country/TerritoryJapan
Original Approved Date1996/07/10
Country/TerritoryCzechiaBulgariaUkraine +[11] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesYamanouchi Pharmaceutical Co LtdAstellas Pharma Inc
Inactive CompaniesAstellas Pharma Europe BvFriends Of The Catholic University Of Korea Inc
Active IndicationsVomitingNauseaIrritable Bowel Syndrome
Inactive IndicationsHematologic Neoplasms

Other Information

ATC CodeA04AA
Related LinksWikipediaDrugBankKEGG